|
Despite the withdrawal, enrolment continues in the IDeate-Lung02 Phase III trial.
|
 |
|
Atebrioz has been developed by Incyte and licensed to Mirum for global commercialisation.
|
|
|
A growing number of FDA-approved innovators and biosimilars are being manufactured at China-based facilities as biopharma takes interest in the country’s biologic API manufacturing industry. However, this is being met with pushback from US policymakers amid efforts to onshore pharmaceutical manufacturing.
|
|
|
Aptar and Macquarie's partnership will evaluate how factors, including how formulation variables influence drug delivery with Aptar’s dry powder inhaler platform.
|
|
|
Despite Dr Heidi Overton’s declaration, senators questioned whether the commissioner-elect would challenge erroneous statements from the President.
|
|
